BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$421M |
| 2 |
McDonald's
MCD
|
+$326M |
| 3 |
Gilead Sciences
GILD
|
+$226M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$204M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 2 |
Canadian Pacific Kansas City
CP
|
+$593M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$374M |
| 4 |
Toronto Dominion Bank
TD
|
+$279M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.42% |
| 2 | Financials | 3.25% |
| 3 | Healthcare | 2.43% |
| 4 | Communication Services | 2.21% |
| 5 | Consumer Discretionary | 1.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Tempest Therapeutics
TPST
$18.7M
| – | – |
0
| – | – |
|
|
SMRT
3127
DELISTED
Stein Mart Inc
SMRT
| $19K | ﹤0.01% |
+1,642
| New | +$21.2K |
|
3128
Lexicon Pharmaceuticals
LXRX
$1.04B
| $19K | ﹤0.01% |
+1,921
| New | +$20.5K |
|
3129
Park-Ohio Holdings
PKOH
$718M
| $19K | ﹤0.01% |
+396
| New | +$22.7K |
|
|
SSNI
3130
DELISTED
Silver Spring Networks, Inc.
SSNI
| $18.9K | ﹤0.01% |
1,961
+1,926
| +5,503% | +$21K |
|
|
FMI
3131
DELISTED
Foundation Medicine, Inc.
FMI
| $18.9K | ﹤0.01% |
+998
| New | +$23.8K |
|
3132
Applied Optoelectronics
AAOI
$11B
| $18.9K | ﹤0.01% |
1,175
+1,140
| +3,257% | +$22.6K |
|
3133
Great Elm Group
GEG
$67.4M
| $18.9K | ﹤0.01% |
+845
| New | +$20.6K |
|
3134
First Bancorp
FBNC
$2.74B
| $18.9K | ﹤0.01% |
+1,177
| New | +$20K |
|
3135
MACOM Technology Solutions
MTSI
$23.5B
| $18.8K | ﹤0.01% |
+863
| New | +$19.2K |
|
3136
Dime Commercial Bancshares
DCOM
$1.82B
| $18.8K | ﹤0.01% |
+796
| New | +$19.3K |
|
3137
Limoneira
LMNR
$250M
| $18.8K | ﹤0.01% |
+794
| New | +$18.2K |
|
3138
Middlesex Water
MSEX
$1.11B
| $18.7K | ﹤0.01% |
956
+817
| +588% | +$16.7K |
|
|
LIOX
3139
DELISTED
Lionbridge Technologies
LIOX
| $18.7K | ﹤0.01% |
4,155
+3,931
| +1,755% | +$20.1K |
|
|
CUDA
3140
DELISTED
Barracuda Networks, Inc.
CUDA
| $18.7K | ﹤0.01% |
+728
| New | +$20.5K |
|
3141
Evolution Petroleum
EPM
$135M
| $18.7K | ﹤0.01% |
2,032
+1,018
| +100% | +$10.5K |
|
3142
Pacific Biosciences
PACB
$357M
| $18.6K | ﹤0.01% |
3,793
+3,653
| +2,609% | +$19.1K |
|
3143
VSE Corp
VSEC
$6.48B
| $18.6K | ﹤0.01% |
758
+514
| +211% | +$15.8K |
|
3144
Stoneridge
SRI
$201M
| $18.6K | ﹤0.01% |
1,647
+1,150
| +231% | +$13.4K |
|
|
NBBC
3145
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
| $18.5K | ﹤0.01% |
2,438
+2,199
| +920% | +$16.8K |
|
|
ECYT
3146
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $18.5K | ﹤0.01% |
+3,040
| New | +$20.8K |
|
|
CIM
3147
Chimera Investment
CIM
$993M
| $18.5K | ﹤0.01% |
405
-2,012
| -83% | -$96.9K |
|
3148
Daily Journal
DJCO
$828M
| $18.4K | ﹤0.01% |
102
+40
| +65% | +$7.42K |
|
3149
Chefs' Warehouse
CHEF
$4.57B
| $18.4K | ﹤0.01% |
1,132
+890
| +368% | +$15.8K |
|
3150
TG Therapeutics
TGTX
$7.34B
| $18.3K | ﹤0.01% |
1,718
+1,042
| +154% | +$9.66K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2014 Portfolio in Review
As of Q3 2014, BNP Paribas Financial Markets held 4,559 positions worth $115B, up 8.1% from $106B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
BNP Paribas Financial Markets deployed $7.55B of net new capital in Q3 2014, opening 739 new positions and adding to 2,386 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 125,616 shares worth $34.6M.
By sector, the portfolio is most concentrated in Technology at 5.4% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.13B trimmed.
- BNP Paribas Financial Markets's largest Q3 2014 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 125,616 shares worth $34.6M.
- BNP Paribas Financial Markets added most to Alphabet (Google) Class C in Q3 2014, an estimated $421M increase.
- BNP Paribas Financial Markets's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.13B.
- BNP Paribas Financial Markets fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $21.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 40% of its $115B portfolio in Q3 2014.
- BNP Paribas Financial Markets opened 739 new positions and closed 458 in Q3 2014.
- BNP Paribas Financial Markets's portfolio value rose 8.1% quarter-over-quarter to $115B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.